Search research articles
Contact Us
Filters
Showing results (901-910 of 920) with videos related to
Page
of 92
Sort By:
ACS Medicinal Chemistry Letters
|
November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors
Derun Li, Hongjun Zhang, Thomas W Lyons, et al.
ACS Medicinal Chemistry Letters
|
September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology
Min Lu, Hongjun Zhang, Derun Li, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy
Matthew J Mitcheltree, Derun Li, Abdelghani Achab, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia
Sampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.
BMC Medical Research Methodology
|
February 19, 2013
Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
Fay Crawford, Chantelle Anandan, Francesca M Chappell, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
Anandan Palani, Ashwin U Rao, Xiao Chen, et al.
ACS Medicinal Chemistry Letters
|
July 24, 2018
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma
Xianhai Huang, Jason Brubaker, Wei Zhou, et al.
BMJ Open Respiratory Research
|
April 8, 2021
Symptomatic, biochemical and radiographic recovery in patients with COVID-19
Patrick Mallia, Jamilah Meghji, Brandon Wong, et al.
Advanced Healthcare Materials
|
May 29, 2025
Immunosuppressive Formulations for Immunological Defense against Traumatic Brain Injury
Kelly Lintecum, Abhirami Thumsi, Kara Dunn, et al.
The Journal of Infectious Diseases
|
March 3, 2022
Cost of Illness Due to Severe Enteric Fever in India
Dilesh Kumar, Atul Sharma, Saroj Kumar Rana, et al.
Page
of 92
Search research articles
Search
Showing results (901-910 of 920) with videos related to
Sort By:
Page
of 92
ACS Medicinal Chemistry Letters
|
November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors
Derun Li, Hongjun Zhang, Thomas W Lyons, et al.
ACS Medicinal Chemistry Letters
|
September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology
Min Lu, Hongjun Zhang, Derun Li, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy
Matthew J Mitcheltree, Derun Li, Abdelghani Achab, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia
Sampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.
BMC Medical Research Methodology
|
February 19, 2013
Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
Fay Crawford, Chantelle Anandan, Francesca M Chappell, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
Anandan Palani, Ashwin U Rao, Xiao Chen, et al.
ACS Medicinal Chemistry Letters
|
July 24, 2018
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma
Xianhai Huang, Jason Brubaker, Wei Zhou, et al.
BMJ Open Respiratory Research
|
April 8, 2021
Symptomatic, biochemical and radiographic recovery in patients with COVID-19
Patrick Mallia, Jamilah Meghji, Brandon Wong, et al.
Advanced Healthcare Materials
|
May 29, 2025
Immunosuppressive Formulations for Immunological Defense against Traumatic Brain Injury
Kelly Lintecum, Abhirami Thumsi, Kara Dunn, et al.
The Journal of Infectious Diseases
|
March 3, 2022
Cost of Illness Due to Severe Enteric Fever in India
Dilesh Kumar, Atul Sharma, Saroj Kumar Rana, et al.
Page
of 92